Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly targeting tyrosine kinases involved in cancer cell proliferation. Shows potential in developing anti-tumor agents due to its ability to modulate signaling pathways in oncology studies. Also employed in the design of selective protein inhibitors for inflammatory and neurodegenerative diseases. Its structural features support binding to ATP-binding sites in enzymes, making it valuable in structure-activity relationship (SAR) studies for drug optimization.